Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid

US11208673B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11208673-B2
Application numberUS-201816213671-A
CountryUS
Kind codeB2
Filing dateDec 7, 2018
Priority dateMay 7, 2009
Publication dateDec 28, 2021
Grant dateDec 28, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring microbial organism, comprising a microbial organism having a 6-aminocaproic acid (6-ACA) pathway comprising at least two exogenous nucleic acids encoding 6-ACA pathway enzymes expressed in a sufficient amount to produce 6-ACA from glutamate, said 6-ACA pathway enzymes comprising: a glutamyl-CoA transferase or a glutamyl-CoA ligase; a beta-ketothiolase; an 3-oxo-6-aminopimeloyl-CoA oxidoreductase; a 3-hydroxy-6-aminopimeloyl-CoA dehydratase; a 6-amino-7-carboxyhept-2-enoyl-CoA reductase; 6-aminopimeloyl-CoA hydrolase, transferase and/or ligase; and a 2-aminopimelate decarboxylase. 2. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism comprises a set of exogenous nucleic acids encoding 6-ACA pathway enzymes expressed in a sufficient amount to produce 6-ACA, said set of exogenous nucleic acids comprising: a glutamyl-CoA transferase or a glutamyl-CoA ligase; a beta-ketothiolase; a 3-oxo-6-aminopimeloyl-CoA oxidoreductase; a 3-hydroxy-6-aminopimeloyl-CoA dehydratase; a 6-amino-7-carboxyhept-2-enoyl-CoA reductase; 6-aminopimeloyl-CoA hydrolase, transferase and/or ligase; and a 2-aminopimelate decarboxylase. 3. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least three exogenous nucleic acids. 4. The non-naturally occurring microbial organism of claim 1 , wherein said exogenous nucleic acid is a heterologous nucleic acid. 5. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in culture medium, wherein said culture medium is in an atmosphere of less than 1% oxygen or comprises dissolved oxygen in an amount that is less than 10% of saturation. 6. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least four exogenous nucleic acids. 7. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least five exogenous nucleic acids. 8. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least six exogenous nucleic acids. 9. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least seven exogenous nucleic acids. 10. The non-naturally occurring microbial organism of claim 1 , wherein said 6-ACA pathway comprises at least eight exogenous nucleic acids. 11. A method for producing 6-aminocaproic acid (6-ACA), comprising culturing a non-naturally occurring microbial organism of claim 5 under conditions and for a sufficient period of time to produce 6-ACA. 12. The non-naturally occurring microbial organism of claim 1 , part (iv), further comprising a 2-amino-7-oxosubarate pathway comprising at least one exogenous nucleic acid encoding a 2-amino-7-oxosubarate pathway enzyme expressed in a sufficient amount to produce 2-amino-7-oxosubarate, said 2-amino-7-oxosubarate pathway comprising a 2-amino-5-hydroxy-7-oxosubarate aldolase, a 2-amino-5-hydroxy-7-oxosubarate dehydratase, or a 2-amino-5-ene-7-oxosubarate reductase. 13. The non-naturally occurring microbial organism of claim 2 , part (v), further comprising a 2-amino-7-oxosubarate pathway comprising a second set of exogenous nucleic acids encoding 2-amino-7-oxosubarate pathway enzymes expressed in a sufficient amount to produce 2-amino-7-oxosubarate, said second set of exogenous nucleic acids encoding a 2-amino-5-hydroxy-7-oxosubarate aldolase; a 2-amino-5-hydroxy-7-oxosubarate dehydratase; and a 2-amino-5-ene-7-oxosubarate reductase. 14. A method for producing 6-aminocaproic acid (6-ACA), comprising culturing a non-naturally occurring microbial organism of claim 1 under conditions and for a sufficient period of time to produce 6-ACA.

Assignees

Inventors

Classifications

  • Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

  • Amines; Imines · CPC title

  • C12P17/10Primary

    Nitrogen as only ring hetero atom · CPC title

  • Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

  • containing a carboxyl group {including Peroxycarboxylic acids} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11208673B2 cover?
The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for …
Who is the assignee on this patent?
Genomatica Inc
What technology area does this patent fall under?
Primary CPC classification C12P17/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).